In vivo receptor occupancy of mGlu5 receptor antagonists using the novel radioligand [ 3 H]3-methoxy-5-(pyridin-2-ylethynyl)pyridine)

Author： Anderson J.J.   Bradbury M.J.   Giracello D.R.   Chapman D.F.   Holtz G.   Roppe J.   King C.   Cosford N.D.P.   Varney M.A.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.473, Iss.1, 2003-07, pp. : 35-40

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Preclinical Pharmacology of mGlu2 / 3 Receptor Agonists: Novel Agents for Schizophrenia?

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 1, Iss. 2, 2002-04 ,pp. : 215-225

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in Non-Competitive mGlu5 Receptor Antagonists and their Potential Therapeutic Applications

By  

Current Topics in Medicinal Chemistry, Vol. 5, Iss. 9, 2005-01 ,pp. : 897-911

Bentham Science Publishers

Access to resources Recommend Favorite

Novel heterocyclic compounds as mGlu5 antagonists: WO2009015897

By Doller Dario   Li Guiying   Brodbeck Robbin M   Thomsen Christian  

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 3, 2010-03 ,pp. : 435-439

Informa Healthcare

Access to resources Recommend Favorite

5-HT3 receptor antagonists

By Higgins G.A.   Kilpatrick G.J.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 12, 1999-12 ,pp. : 2183-2188

Informa Healthcare

Access to resources Recommend Favorite

The quest for treatment of cognitive impairment: AMPA and mGlu5 receptor modulators

By Sun Miao-Kun  

Expert Opinion on Therapeutic Patents, Vol. 18, Iss. 9, 2008-09 ,pp. : 999-1010

Informa Healthcare

Access to resources Recommend Favorite